Hippocampal CA1 neuron survival and cytosolic FKBP12, the 12 kDa FK506-binding protein, after ischemia and tacrolimus treatment in gerbils

Neuroscience Letters

Volumn 339, Issue 3, 2003, Pages 219-222

  Fumoto, Noriyuki ^a   Nakatsuka, Hiroki ^b   Ohta, Shinsuke ^c   Kumon, Yoshiaki ^a   Ohnishi, Takanori ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Saiseikai Saijo Hospital   (Japan)

^c Wakakusa Daiichi Hospital   (Japan)

Author keywords

CA1; Delayed neuronal death; FKBP12; Gerbil; Neuroprotection; Tacrolimus

Indexed keywords

FK 506 BINDING PROTEIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN LEVEL; CELL LEVEL; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; DRUG EFFICACY; GERBIL; HIPPOCAMPUS; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REPERFUSION;

EID: 0345701248     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00025-9     Document Type: Article

References (12)

1. Furuta S., Ohta S., Hatakeyama T., Nakamura K., Sakaki S. Recovery of protein synthesis in tolerance-induced hippocampal CA1 neurons after transient forebrain ischemia. Acta Neuropathol. 86:1993;329-336.
2. Guo X., Dillman J.F. 3rd, Dawson V.L., Dawson T.M. Neuroimmunophilins novel neuroprotective and neuroregenerative targets. Ann. Neurol. 50:2001;6-16.
3. Ide T., Morikawa E., Kirino T. An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the mongolian gerbil. Neurosci. Lett. 204:1996;157-160.
4. Kato H., Oikawa T., Otsuka K., Takahashi A., Itoyama Y. Postischemic changes in the immunophilin FKBP12 in the rat brain. Brain Res. Mol. Brain Res. 84:2000;58-66.
5. Liu J., Farmer J.D. Jr, Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815.
6. Morioka M., Fukunaga K., Kai Y., Todaka T., Yano S., Hamada J., Miyamoto E., Ushio Y. Intravenously injected FK506 failed to inhibit hippocampal calcineurin. Biochem. Biophys. Res. Commun. 286:2001;802-806.
7. Sharkey J., Butcher S.P. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature. 371:1994;336-339.
8. Shibazaki Y., Nakai A., Koshino T., Yokoyama K. Effect of the immunosuppressant drug FK506 on neonatal cerebral mitochondrial function and energy metabolism after transient intrauterine ischemia in rats. Brain Res. 892:2001;351-358.
9. Tokime T., Nozaki K., Kikuchi H. Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. Neurosci. Lett. 206:1996;81-84.
10. Wakita H., Tomimoto H., Akiguchi I., Kimura J. Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. Brain Res. 792:1998;105-113.
11. Widmann R., Weber C., Bonnekoh P., Schlenker M., Hossmann K.A. Neuronal damage after repeated 5 min of ischemia in the gerbil is preceded by prolonged impairment of protein metabolism. J. Cereb. Blood Flow Metab. 12:1992;425-433.
12. Yagita Y., Kitagawa K., Matsushita K., Taguchi A., Mabuchi T., Ohtsuki T., Yanagihara T., Matsumoto M. Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils. Life Sci. 59:1996;1643-1650.